RichardLDemingMD

Radiation Oncology • Des Moines, IA

Medical Director Mercy Cancer Center

Join to view full profile

Dr. Deming is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Deming's full profile

Already have an account?

Office
411 Laurel St
Ste 3300
Des Moines, IA 50314
Phone+1 515-643-8206

Fax+1 515-643-8930

Education & Training

University of California (San Francisco)Residency, Radiation Oncology, 1986 - 1987
Naval Medical Center (San Diego)Residency, Radiation Oncology, 1984 - 1986
Naval Medical Center (San Diego)Internship, Internal Medicine, 1980 - 1981
Creighton University School of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1985 - 2026
IA State Medical License 1989 - 2025
American Board of Radiology Radiation Oncology

Clinical Trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01
Terminated
Phase 2
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum Start of enrollment: 2004 Dec 01
Terminated
Phase 2
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Completed
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
ACTIVE_NOT_RECRUITING
PHASE3
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26
ACTIVE_NOT_RECRUITING
PHASE3
Gemcitabine and Cisplatin Without Cystectomy for Patients with Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Dec 10
RECRUITING
PHASE2
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
ACTIVE_NOT_RECRUITING
PHASE2
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
ACTIVE_NOT_RECRUITING
PHASE3
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
ACTIVE_NOT_RECRUITING
PHASE3
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14
Active, not recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Start of enrollment: 2019 Jul 19
COMPLETED
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients with Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer Start of enrollment: 2020 Aug 13
ACTIVE_NOT_RECRUITING
PHASE3
Serum-derived Bovine Immunoglobulin Effect on Mucositis Start of enrollment: 2020 Jan 17
Terminated
Phase 2
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker Start of enrollment: 2020 Jul 20
ACTIVE_NOT_RECRUITING
PHASE2
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer Start of enrollment: 2020 Dec 09
TERMINATED
PHASE3
Join now to see all

Publications & Presentations

PubMed

1 citations
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Pacli...
Douglas M Dahl, Theodore G Karrison, M Dror Michaelson, Huong T Pham, Chin-Lee Wu
European Urology Oncology. 2024-02-01
8 citations
A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study...
Elizabeth J. Cathcart-Rake, Paul J. Novotny, Roberto A. Leon-Ferre, Jennifer Le-Rademacher, Elizabeth Storrick
Supportive Care in Cancer. 2021-01-01
56 citations
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group ...
Thomas M. Churilla, Karla V. Ballman, Paul D. Brown, Erin Twohy, Kurt A. Jaeckle
International Journal of Radiation Oncology, Biology, Physics. 2017-12-01

Press Mentions

Iowa Maintains Fastest-Growing Cancer Rate as Survivor Numbers GrowFebruary 25th, 2025
Iowans Honored for Work in Cancer Control at Annual Iowa Cancer SummitNovember 1st, 2022
New Cancer Center Opens at MercyOne HospitalJanuary 22nd, 2022
Join now to see all